Impact of Body Mass Index on Patient Outcome in Acute Myeloid Leukemia Patients Receiving Intensive Induction Therapy: A Real-World Registry ExperienceJulius C. Enßle, Björn Steffen, Michael Krämer et al.|Blood|2021Cited by 1
Intensified Cytarabine Dose during Consolidation Therapy in AML Patients Under 65 Years Is Not Associated with Survival BenefitMaher Hanoun, Christoph Röllig, Leo Ruhnke et al.|Blood|2021Cited by 0